SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 263 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $390 | -36.1% | 12,974 | -22.9% | 0.05% | -12.5% |
| Q1 2023 | $610 | -8.5% | 16,830 | -10.1% | 0.06% | -16.4% |
| Q4 2022 | $667 | -99.9% | 18,711 | -26.3% | 0.07% | -18.3% |
| Q4 2021 | $740,000 | +239.4% | 25,382 | +205.5% | 0.08% | +228.0% |
| Q1 2021 | $218,000 | -14.2% | 8,309 | +9.0% | 0.02% | -43.2% |
| Q4 2018 | $254,000 | -66.0% | 7,626 | -59.2% | 0.04% | -66.7% |
| Q4 2017 | $746,000 | – | 18,704 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |